Finance

Lists
Why is OCUL down १६.७४%?
Dive Deeper
OCUL:NASDAQ
Ocular Therapeutix Inc
US$ ८.०४
-१६.७४%
(-१.६१) 1D
सेप्टेम्बर २८, १३:२४:४० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
US$ ९.३८
High
US$ ९.३८
Low
US$ ७.१८
Mkt. cap
१.७६ अरब
Avg. vol.
२६.०५ लाख
Volume
९०.५४ लाख
52-wk high
US$ १६.४४
52-wk low
US$ ६.२३
EPS
-US$ १.४१
Beta
०.९७
Shares outstanding
२१.९६ करोड
No. of employees
३२५
Open
US$ ९.३८
High
US$ ९.३८
Low
US$ ७.१८
Mkt. cap
१.७६ अरब
Avg. vol.
२६.०५ लाख
Volume
९०.५४ लाख
52-wk high
US$ १६.४४
52-wk low
US$ ६.२३
EPS
-US$ १.४१
Beta
०.९७
Shares outstanding
२१.९६ करोड
No. of employees
३२५
News stories
From web sources and news partners
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees३२५
Founded२००६
HeadquartersBedford, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websiteocutx.com
Analyst ratings
Based on 8 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current US$ ८.०४
US$ ३१.०० (+२८५.८१%)
Average
US$ २५.५७ (+२१८.२३%)
Lowest
US$ १८.०० (+१२४.०२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ २५.००
+२११.१%
09/16/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
US$ २७.००
+२३६%
09/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ ३१.००
+२८५.८%
08/26/2026
William Maughan
Clear Street
Buy
Reiterated
US$ २८.००
+२४८.५%
08/18/2026
Serge Belanger
Needham
Buy
Maintained
US$ १८.००
+१२४%
08/17/2026
Tara Bancroft
TD Cowen
Buy
Maintained
US$ २०.००
+१४८.९%
08/03/2026
Lisa Walter
RBC Capital
Buy
Maintained
US$ ३०.००
+२७३.४%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
US$ २३.००
+१८६.२%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
US$ ३०.००
+२७३.४%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
US$ २८.००
+२४८.५%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४५ करोड
१.३२ करोड
१.०८ करोड
१.३५ करोड
Cost of goods sold
५.४१ करोड
५.२४ करोड
६.७५ करोड
५.६१ करोड
Cost of revenue
५.४१ करोड
५.२४ करोड
६.७५ करोड
५.६१ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.९१ करोड
३.०६ करोड
३.६६ करोड
३.९४ करोड
Operating expense
२.९१ करोड
३.०६ करोड
३.६६ करोड
३.९४ करोड
Total operating expenses
८.३२ करोड
८.३० करोड
१०.४१ करोड
९.५६ करोड
Operating income
-६.८७ करोड
-६.९८ करोड
-९.३३ करोड
-८.२१ करोड
Other non operating income
-१४.४७ लाख
६.२४ लाख
१४.५५ लाख
६.८९ लाख
EBT including unusual items
-६.९४ करोड
-६.४७ करोड
-८.८६ करोड
-७.८८ करोड
EBT excluding unusual items
-६.९४ करोड
-६.४६ करोड
-८.८६ करोड
-७.८८ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६.९४ करोड
-६.४७ करोड
-८.८६ करोड
-७.८८ करोड
Net profit margin
-४७७.३०%
-४८७.९५%
-८२१.६२%
-५८४.५१%
Earnings per share
-०.३८
-०.२९
-०.४०
-०.३५
Interest and investment income
३७.२९ लाख
७३.४३ लाख
६०.५० लाख
५४.४९ लाख
Interest expense
-३०.०२ लाख
-२८.३२ लाख
-२७.७७ लाख
-२७.९२ लाख
Net interest expenses
७.२७ लाख
४५.११ लाख
३२.७३ लाख
२६.५७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-६.७६ करोड
-६.८५ करोड
-९.२१ करोड
-८.०३ करोड
Gain or loss from assets sale
-
-
४८.६६ लाख
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू